Clinical trial
PulseSelect PFA Global Registry, a Part of the Medtronic Cardiac Ablation Post-Market Study Platform
NCT06393920 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PulseSelect PFA Global Registry, a Part of the Medtronic Cardiac Ablation Post-Market Study Platform
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 23, 2024
- Completion date
- July 31, 2028
- Enrollment
- 1,950 (estimated)
- Sites
- 43
Conditions
As the registry lists them; a condition with its own page is linked.